CYVNY

0.02800.00%
LB

Lawrence B. Gozlan

Independent Non-Executive Director

Mr. Lawrence B. Gozlan is Independent Non-Executive Director of Ceryvyn Therapeutics Limited (formerly known as Opthea Limited) from July 24, 2020. He joined the Ceryvyn Therapeutics Limited (formerly known as Opthea Limited) on July 24, 2020. He is Non-Executive Director of Alterity Therapeutics Limited from August 08, 2011. He joined the Alterity Therapeutics Limited on August 08, 2011. He is Non-Executive Chair of Enlitic, Inc. He was Executive Chairman of the Board of Enlitic, Inc. from June 2023. He was Director of Enlitic, Inc. until June 2023. He is Director of Faraday Pharmaceuticals, Inc. He is Director of Nohla Therapeutics, Inc. from December 24, 2015. He joined the Nohla Therapeutics, Inc. on December 24, 2015. He is Founder, Chief Investment Officer and Chief Executive Officer of Scientia Capital. He is Strategic Advisor of Proto Axiom Pty Ltd. He was Institutional Biotechnology Analyst of QIC Limited. He was Director of TALi Digital Limited. He was employed at TALi Digital Limited from June 30, 2009 to November 17, 2009. He was Chairman of the Board of Avecho Biotechnology Limited. He was employed at Avecho Biotechnology Limited from February 28, 2014 to May 12, 2015. He was Independent Non-Executive Director of OncoSil Medical Limited. He was employed at OncoSil Medical Limited from February 27, 2014 to May 04, 2015. He was Non-Executive Director of Telesso Technologies Limited. He was employed at Telesso Technologies Limited from April 04, 2007 to October 11, 2013. He was Senior Biotechnology Sell-Side Analyst of Foster Stockbroking Pty Ltd., Research Division. He has B.S. in Immunology & Microbiology from University of Melbourne.

Positions